ʻO ka lawe ʻana i ka lāʻau lapaʻau i manaʻo ʻia no ka maʻi maʻi: He alakaʻi piha

Nūhou

 ʻO ka lawe ʻana i ka lāʻau lapaʻau i manaʻo ʻia no ka maʻi maʻi: He alakaʻi piha 

2025-03-07

Hāʻawi ʻia ka lāʻau lapaʻau no ka maʻi kanesa ka manaʻo e hoʻomaikaʻi i ka maikaʻi o ka mālama ʻana a hōʻemi i nā hopena ʻaoʻao ma o ka hāʻawi ʻana i nā mea lapaʻau i nā maʻi maʻi maʻi ʻoiai e mālama ana i nā ʻiʻo olakino. Hoʻohana kēia ala i nā mea lawe like ʻole a me nā hoʻolālā hoʻolālā e hoʻonui i ka hōʻiliʻili lāʻau i loko o ka microenvironment tumor, e alakaʻi ana i ka hopena o ka maʻi.

ka hoomaopopo ana Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi

He aha ka Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi?

Hāʻawi ʻia ka lāʻau lapaʻau no ka maʻi kanesa he ala maʻalahi o ka lawelawe ʻana i ka lāʻau lapaʻau i nā pūnaeau maʻi maʻi. ʻAʻole e like me ka chemotherapy maʻamau, e pili ana i ke kino holoʻokoʻa, ʻo nā ʻōnaehana hoʻopuka i manaʻo ʻia e nānā pono i ka hāʻawi ʻana i nā lāʻau lapaʻau i ka pūnaewele tumora. Hoʻemi kēia ala i ka pōʻino i nā ʻiʻo olakino a hōʻemi i nā hopena ʻaoʻao koʻikoʻi i pili pinepine ʻia me nā lāʻau lapaʻau maʻamau.

No ke aha Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi Mea nui?

ʻO ka pahuhopu mua o ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa ʻo ia ka hoʻomaikaʻi ʻana i ka maikaʻi o ka mālama ʻana i ka maʻi maʻi ʻoiai e hōʻemi ana i nā hopena ʻona i nā cell olakino. Ma ka hāʻawi pololei ʻana i nā lāʻau lapaʻau i ka ʻōpū, hiki ke hoʻokō ʻia nā kiʻekiʻe kiʻekiʻe o ka lāʻau lapaʻau ma ka wahi i hoʻopaʻa ʻia, e hoʻomaikaʻi ana i nā manawa o ka mālama kūleʻa. Hoʻemi kēia i ka ʻike ʻana o ka ʻōnaehana i ka lāʻau lapaʻau, e alakaʻi ana i ka liʻiliʻi a me ka liʻiliʻi o nā hopena koʻikoʻi no ka mea maʻi.

ʻO ka lawe ʻana i ka lāʻau lapaʻau i manaʻo ʻia no ka maʻi maʻi: He alakaʻi piha

Hoʻokokoke i Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi

Hoʻopaʻa ʻia ʻana

Ke hilinaʻi nei ka huli ʻana i nā hiʻohiʻona kūlohelohe o nā ʻōpū, e like me kā lākou leaky vasculature a me ka hoʻohaʻahaʻa lymphatic impaired, e ʻae i nā lāʻau e hōʻiliʻili i loko o ka microenvironment tumor. Hiki i nā nanoparticles me ka nui kūpono a me ka waiwai o ka ʻili ke hoʻohana i kēia mau hiʻohiʻona e hoʻopaʻa paʻa i nā ʻōpū. ʻO kekahi laʻana, ʻo ia nā liposomes he vesicles spherical i haku ʻia me nā lipid bilayers.

Hoʻopalau ʻeleu

ʻO ka hoʻoikaika ʻana e pili ana i ka hoʻololi ʻana i nā mea lawe lāʻau me nā ligand kikoʻī e hoʻopaʻa ʻia i nā mea hoʻokipa i hōʻike nui ʻia ma nā cell cancer. Hoʻomaʻamaʻa kēia pilina i ka lawe ʻana i ka mea lawe lāʻau e nā maʻi kanesa. ʻO nā ligand maʻamau e pili ana i nā antibodies, peptides, a me nā aptamers.

ʻO ka hoʻoulu ʻana-pane ʻana

Hoʻohana ka stimuli-responsive targeting i nā mea hoʻoulu i loko a i waho paha, e like me ka pH, ka mahana, a i ʻole ka māmā, e hoʻomaka ai i ka hoʻokuʻu ʻana i ka lāʻau lapaʻau ma ka pūnaewele tumor. Hāʻawi kēia ala i ka mana pololei ma luna o ka lawe ʻana i ka lāʻau lapaʻau, e hoʻonui i ka hopena therapeutic aʻo ka hōʻemi ʻana i nā hopena o waho. ʻO nā nanoparticles koʻikoʻi pH, no ka laʻana, e hoʻokuʻu i kā lākou uku lāʻau i loko o ke kaiapuni waikawa o ka microenvironment tumor.

Hoʻohana ʻia nā mea lawe ma Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi

Nanoparticles

Hoʻohana nui ʻia nā nanoparticles e like me nā mea lawe i loko ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa ma muli o ko lākou liʻiliʻi liʻiliʻi, ka ʻili nui, a me ka versatility. Hiki iā lākou ke hana ʻia mai nā mea like ʻole, me nā lipids, polymers, a me nā pūhui inorganic. Hiki ke hana ʻia nā nanoparticles e hoʻopili i nā lāʻau lapaʻau, pale iā lākou mai ka hoʻohaʻahaʻa ʻana, a hoʻomaʻamaʻa i kā lākou hāʻawi ʻia ʻana i nā maʻi kanesa. ʻO ka Shandong Baofa Cancer Research Institute hoʻohana i nā ʻano nanoparticles i kā lākou noiʻi ʻana i nā lāʻau lapaʻau maʻi maʻi hou.

Liposome

ʻO nā liposome he mau vesicles spherical i haku ʻia me nā lipid bilayers. He biocompatible, biodegradable, a hiki ke hoʻopili i nā lāʻau hydrophilic a me hydrophobic. Hiki ke hoʻololi ʻia nā liposome me nā ligands e hoʻonui i kā lākou koho no nā maʻi maʻi maʻi.

ʻO nā mea hoʻohui lāʻau antibody (ADC)

Hoʻokumu ʻia nā ADC me kahi antibody monoclonal i hoʻopili ʻia i kahi lāʻau cytotoxic. Hoʻopili paʻa ka antibody i nā pūnaeau maʻi kanesa, e hāʻawi pololei ana i ka lāʻau lapaʻau i ka pūnaewele tumor. Hoʻohui kēia ala i ka kikoʻī o nā antibodies me ka ikaika o nā lāʻau cytotoxic.

ʻO ka lawe ʻana i ka lāʻau lapaʻau i manaʻo ʻia no ka maʻi maʻi: He alakaʻi piha

Nā laʻana o Hoʻouna ʻia i ka lāʻau lapaʻau no ka maʻi maʻi maʻi i ka hoʻohana lāʻau lapaʻau

Doxil? (Liposomal Doxorubicin)

Doxil? he hana liposomal o doxorubicin, he lāʻau chemotherapy anthracycline. ʻO ka liposomal encapsulation o doxorubicin e hoʻolōʻihi i kona manawa kaʻa a hoʻonui i kona hōʻiliʻili ʻana i nā ʻōpū me ka leaky vasculature. Doxil? ua ʻae ʻia no ka mālama ʻana i ka maʻi maʻi ovarian, myeloma lehulehu, a me ka sarcoma o Kaposi.

Kadcyla? (Trastuzumab Emtansine)

Kadcyla? he ADC i haku ʻia me trastuzumab, he antibody monoclonal e kuhikuhi ana i ka HER2, i hoʻopili ʻia me ka emtansine, kahi mea hoʻopaneʻe microtubule. Kadcyla? ua ʻae ʻia no ka mālama ʻana i ka maʻi maʻi umauma metastatic HER2 maikaʻi. ʻO ka ʻāpana trastuzumab o Kadcyla? hoʻopaʻa i ka HER2-maikaʻi o ka maʻi kanesa, hāʻawi pololei i ka emtansine i ka pūnaewele tumor.

Nā Luʻi a me nā kuhikuhi e hiki mai ana

Ka Lanakila ʻana i nā Paʻi Ola

ʻO kekahi o nā pilikia nui ma ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa ke lanakila nei i nā pale olaola, e like me ka pale koko-lolo a me ka microenvironment tumor. ʻO nā hoʻolālā no ka lanakila ʻana i kēia mau pale, ʻo ia ka hoʻohana ʻana i nā nanoparticles liʻiliʻi, ka hoʻololi ʻana i kā lākou mau waiwai o ka ʻili, a me ka hoʻohana ʻana i ka stimuli-responsive targeting.

Hoʻomaikaʻi ʻana i ka kikoʻī kikoʻī

ʻO ka hoʻomaikaʻi ʻana i ka kikoʻī o nā ʻōnaehana hoʻopuka lāʻau i manaʻo ʻia he mea koʻikoʻi ia e hōʻemi i nā hopena o waho a hoʻonui i ka hopena therapeutic. Hiki ke hoʻokō ʻia kēia ma o ka hoʻomohala ʻana i nā ligand koho, ka hoʻolālā ʻana i ka hoʻolālā o nā mea lawe lāʻau, a me ka hoʻohana ʻana i nā lāʻau lapaʻau hui.

Lapaau Pilikino

ʻO nā ala lapaʻau pilikino i hoʻohiki nui no ka hoʻomaikaʻi ʻana i ka pono o ka lawe ʻana i ka lāʻau lapaʻau no ka maʻi kanesa. Ma ka hoʻohālikelike ʻana i nā hoʻolālā lapaʻau i nā hiʻohiʻona o kēlā me kēia maʻi a me ko lākou maʻi maʻi, hiki paha ke hoʻonui i ka lawe ʻana i ka lāʻau a hoʻonui i nā hopena lapaʻau. Hoʻopili paha kēia i ka nānā ʻana i ka moʻo o ka ʻōpū e ʻike i nā pahuhopu kikoʻī no ka lawe ʻana i ka lāʻau.

Papa o ka FDA-Aponoia Manawa Laau Laau Hoolaha no ka ma'i ma'i

Inoa Laau Laau Kuhikuhi ʻAno maʻi maʻi maʻi Mechanism of Action
Doxil? ʻO ka maʻi puʻupuʻu Ovarian Cancer, Multiple Myeloma, Kaposi's Sarcoma ʻO ka lōʻihi o ka holoʻana, hoʻonui i ka hōʻiliʻili i nā maʻi koko
Kadcyla? HE2 HER2-Poitive Metastatic Breast Cancer ʻO ka antibody i hoʻopaʻa ʻia e HER2 i hoʻopili ʻia i kahi mea paʻa microtubule
Enhertu? HE2 HER2-Maʻi maʻi maʻi umauma Hoʻopili ʻia ka antibody HER2 i hoʻopaʻa ʻia i kahi mea hoʻopaneʻe topoisomerase I

Hōʻole: No ka ʻike wale nō kēia ʻatikala a ʻaʻole pono e manaʻo ʻia he ʻōlelo aʻoaʻo olakino. Kūkākūkā me kekahi ʻoihana mālama ola kūpono no ka ʻike a me ka mālama ʻana i ka maʻi kanesa.

Home
Nā hihia maʻamau
No makou
Hoʻokaʻaʻike iā mākou

E ʻoluʻolu e waiho i kahi leka iā mākou